SCHEMBL160132

SCHEMBL160132

CCC[C@](C)(N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL716231 1.00
SCHEMBL574413 1.00
Hydrochloric Acid SCHEMBL27850578 0.97 GGT1 (0.56)
Hydrochloric Acid SCHEMBL1807627 0.97 GGT1 (0.56)
SCHEMBL3419888 0.87 ARG1 (0.52)
SCHEMBL8687592 0.86 GGT1 (0.65)
SCHEMBL18124758 0.85 ARG1 (0.59)
SCHEMBL186714 0.85 ARG1 (0.59)
SCHEMBL162337 0.85 ARG1 (0.59)
Hydrochloric Acid SCHEMBL18109448 0.83 ARG1 (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1731 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170106344-A1 CONDITIONED SURFACES FOR IN SITU MOLECULAR ARRAY SYNTHESIS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2017-04-20 US claimed
CN-101691334-B Method for preparing D-2-aminobutyric acid or L-2-aminobutyric acid by chemical resolution method NANJING INST ENGINEERING 2012-12-12 CN claimed
CN-102558012-A Synthesis method of levetiracetam TAIZHOU ZHIQING CHEMICAL CO LTD 2012-07-11 CN claimed
CN-102432413-A Purification method for improving chiral purity of D-amino acid UNIV CHONGQING POSTS & TELECOM 2012-05-02 CN claimed
JP-4511835-B2 2010-07-28 JP claimed
US-20090215895-A1 Therapeutic and carrier molecules PEPLIN BIOLIPIDS PTY LTD (AU) 2009-08-27 US claimed
US-7256172-B1 Method of treatment and agents useful for same THE UNIVERSITY OF MELBOURNE (AU) 2007-08-14 US claimed
US-20040259930-A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof MALESCI INSTITUTO FARMACOBIOLOGICO S.P.A. (IT) 2004-12-23 US claimed
EP-1442050-A2 LINEAR BASIC COMPOUNDS HAVING NK-2 ANTAGONIST ACTIVITY AND FORMULATIONS THEREOF MALESCI ISTITUTO FARMACOBIOLOGICO S.p.A. (IT) 2004-08-04 EP claimed
WO-2003037916-A2 LINEAR BASIC COMPOUNDS HAVING NK-2 ANTAGONIST ACTIVITY AND FORMULATIONS THEREOF MALESCI ISTITUTO FARMACOBIOLOGICO S.P.A. (IT) 2003-05-08 WO claimed
EP-0458307-B1 Method for stabilizing taste-modifier KURIHARA YOSHIE (JP) 1995-10-18 EP claimed
EP-0458307-A1 Method for stabilizing taste-modifier Kurihara, Yoshie (JP) 1991-11-27 EP claimed
WO-2026085582-A1 PROTEIN CAGES THE UNIVERSITY OF SYDNEY (AU) 2026-04-30 WO disclosed
EP-4731645-A1 SYNTHESIS OF GLP-1R/GIPR AGONISTS AND PRECURSORS THEREOF Carmot Therapeutics Inc. (US) 2026-04-29 EP disclosed
US-20260069728-A1 MULTI-TARGETING COMPOUND AND USE THEREOF CHENGDU SHETAI MEDICAL TECHNOLOGY CO., LTD. (CN) 2026-03-12 US disclosed
US-20250319054-A1 Synthetic Eicosanoid Analogues for the Treatment and Prevention of Diseases Associated with Increased GDF15 Plasma Concentration OMEICOS THERAPEUTICS GMBH (DE) 2025-10-16 US disclosed
WO-1994011388-A1 SUPPORT FOR THE SYNTHESIS OF MODULAR POLYMERS CHIRON MIMOTOPES PTY. LTD. (AU) 1994-05-26 WO disclosed
WO-1994003483-A1 ENDOTHELIN RECEPTOR-BINDING COMPOUNDS CHIRON CORPORATION (US) 1994-02-17 WO disclosed
US-5210025-A Culturing escherichia coli transformed with genetic vectors in the presence of transcriptional inducing agents UNIVERSITY OF ALASKA (US) 1993-05-11 US disclosed
EP-0458307-A1 Method for stabilizing taste-modifier Kurihara, Yoshie (JP) 1991-11-27 EP disclosed